.
The age distribution of the 3039 registrations treated for carcinoma of the lung is remarkably similar for males and females, with mean ages respectively 64-5 years and 64-2 years. For the 667 untreated registrations the mean ages are some four years older, 68 1 years for both males and females. These mean ages compare with 66-9 years and 66-3 years for the 1977 OPCS cancer incidence data for males and females, England and Wales, but are higher than those quoted for the United States 1961 -1973 USDHHS (1976 which are 62 years for males and 59 years for females. The mean ages for each sex for the three main histological groups, squamous cell carcinoma, oat cell carcinoma and adenocarcinoma, do not differ by greater than 3-5 years.
The crude survival rates for untreated carcinoma of the lung in males and females are shown in Fig. 1 for 0-12 months. The one-year relative survival rates for males and females are 9' 9 % and 6 1 % compared with the 9-3% and 5.9% crude 1-year rates. Fig. 2 shows the crude survival rates for 0-60 months for treated carcinoma of the lung in males and females. The 5-year relative survival rates for males and females are 10.7% and 8.3% compared with the 8.6% and 7.3% crude 5-year rates. Table I shows the crude and relative 1-year and 5-year survival rates for 3039 treated lung cancer registrations, grouped by sex and histology. Some publications use oat carcinoma synonymously with small cell carcinoma, but since for males 238 registrations were specifically recorded as oat cell compared with only 29 as small cell, and for females 196 oat cell compared with 23 small cell, it was decided to retain the original record descriptions and analyse in terms of specified oat cell carcinoma. Other histological groups such as large cell carcinoma and alveolar cell carcinoma were too small in sample size for analysis.
The most extensive published data on untreated cancer is due to Greenwood (1926) and Shimkin (1951) but neither includes data for untreated lung cancer. Fig. 1 Table. For a disease such as lung cancer, the 5-year survival rate is clearly not a good criterion of treatment success and a 1-year rate is more realistic. For example, for both males and females, the improvement in the 1-year survival rate is some 20% when the patients are treated, compared with when they are untreated. Differences between survivals for males and females is not large for any histological sub-group. However, for adenocarcinoma, the 1-year relative rates differ by more than 5%. In this instance, males have a 1-year survival rate 8% higher than for females, although when the 5-year survival rates are considered, survival is 6% higher for females than for males. A similar difference was also reported in the United States (USDHHS, 1976 (USDHHS, ), for adenocarcinoma, 1960 (USDHHS, -1973 , with a 10% 5-year relative survival rate for males and a 14% 5-year relative survival rate for females.
This review refers only to histologically confirmed registrations since these are "good" data in that a verified histology has been recorded in the routine registration system with sufficient accuracy to enable a survival analysis by histological group to be made. Also, the population of the North West Thames region is such that the regional data can be regarded as a reasonably representative sample from England and Wales. The most recently published OPCS (1982) In the North West Thames Region, a significant number of lung cancer registrations are untreated and it is probable that this pattern is repeated throughout England and Wales. Analysis of lung cancer registrations for survival patterns should therefore be made on a basis of treated and untreated series of cases, otherwise a combination of all the registrations cannot be assumed to provide the best estimate of the overall results of treatment within a large population such as a region. When data on histological verification are recorded this should be used for survival analysis, rather than be discarded, as at present occurs at OPCS for England and Wales.
